Logo image of MHLD

MAIDEN HOLDINGS LTD (MHLD) Stock Fundamental Analysis

NASDAQ:MHLD - Nasdaq - BMG5753U1128 - Common Stock - Currency: USD

0.7971  +0.05 (+6.25%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to MHLD. MHLD was compared to 144 industry peers in the Insurance industry. MHLD has a bad profitability rating. Also its financial health evaluation is rather negative. MHLD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MHLD had negative earnings in the past year.
In the past year MHLD has reported a negative cash flow from operations.
In multiple years MHLD reported negative net income over the last 5 years.
MHLD had a negative operating cash flow in each of the past 5 years.
MHLD Yearly Net Income VS EBIT VS OCF VS FCFMHLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -4.58%, MHLD is doing worse than 91.61% of the companies in the same industry.
With a Return On Equity value of -30.63%, MHLD is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.58%
ROE -30.63%
ROIC N/A
ROA(3y)1.82%
ROA(5y)0.89%
ROE(3y)11.41%
ROE(5y)4.63%
ROIC(3y)N/A
ROIC(5y)N/A
MHLD Yearly ROA, ROE, ROICMHLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80 -100

1.3 Margins

MHLD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MHLD Yearly Profit, Operating, Gross MarginsMHLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100

More info and screens

0

2. Health

2.1 Basic Checks

MHLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MHLD has been reduced compared to 1 year ago.
MHLD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MHLD is higher compared to a year ago.
MHLD Yearly Shares OutstandingMHLD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MHLD Yearly Total Debt VS Total AssetsMHLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

MHLD has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
MHLD has a Debt to Equity ratio of 1.22. This is amonst the worse of the industry: MHLD underperforms 87.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.28%
MHLD Yearly LT Debt VS Equity VS FCFMHLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MHLD Yearly Current Assets VS Current LiabilitesMHLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for MHLD have decreased strongly by -369.83% in the last year.
MHLD shows a small growth in Revenue. In the last year, the Revenue has grown by 4.74%.
The Revenue for MHLD have been decreasing by -47.89% on average. This is quite bad
EPS 1Y (TTM)-369.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)4.74%
Revenue growth 3Y-23.55%
Revenue growth 5Y-47.89%
Sales Q2Q%-15.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHLD Yearly Revenue VS EstimatesMHLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B
MHLD Yearly EPS VS EstimatesMHLD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MHLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MHLD Price Earnings VS Forward Price EarningsMHLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MHLD Per share dataMHLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MHLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAIDEN HOLDINGS LTD

NASDAQ:MHLD (3/7/2025, 8:00:01 PM)

0.7971

+0.05 (+6.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-17 2025-03-17
Inst Owners33.42%
Inst Owner Change-0.46%
Ins Owners21.28%
Ins Owner Change-0.01%
Market Cap79.17M
Analysts43.33
Price TargetN/A
Short Float %2.3%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.38
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.8
BVpS2.1
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.58%
ROE -30.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.82%
ROA(5y)0.89%
ROE(3y)11.41%
ROE(5y)4.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-369.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.74%
Revenue growth 3Y-23.55%
Revenue growth 5Y-47.89%
Sales Q2Q%-15.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.35%
OCF growth 3YN/A
OCF growth 5YN/A